ULTIMA II BEAUTIFUL NUTRIENT, VITAL RADIANCE LAUNCH BRAND's "NOURISHING" POSITIONING as cosmetics that moisturize the skin as well as add color, the Revlon division said. Ultima II, which has long-established itself in the color cosmetics arena, said the launch of Beautiful Nutrient lipcolor and Vital Radiance sheer makeup will set the stage for an aggressive move into color products that "look good and are good for you." The strategy also provides a renewed focus on the Ultima II brand, which historically has received less attention than the Revlon stable of cosmetics products.
Join thousands of industry professionals who rely on HBW Insight for daily insights
Already a subscriber?
The US FTC’s contention that ‘notice and choice’ has failed as the cornerstone of consumer privacy regulation and must be abandoned in favor of data minimization and other more stringent measures does not adequately account for the complexity of business practices and consumer behavior, FTC commissioner Melissa Holyoak asserted at the NAD’s 2024 Annual Conference.
FTC Commissioner Melissa Holyoak says the agency has acted outside the bounds afforded by Congress, citing several areas within consumer protection, including a recent update to the final rule for the Health Breach Notification Rule and the commission’s use of notices of penalty offense to serve as the basis for Section 5 settlements.
At one year, TikTok Shop conjures the early days of Amazon, representing the ‘Wild West’ of beauty ecommerce, said co-founders of private label and contract manufacturing company KO-Pack at the IBA Cosmetics Convergence Fall 2024 Virtual Symposium, “The Promise and Pitfalls of TikTok Shop.”
Editor’s note: This is your final call to participate in the survey to better understand our subscribers’ content and delivery needs. The deadline is 20 September.
French SME association COSMED will push the European Commission for a “clear checklist” and criteria on how substances in the Cosmetic Products Regulation are assessed by Member States, as well as more clarity on the exemption process and timelines.
The budget authority total, which is significantly higher than the amount floated in an April OMB draft document, suggests there may have been successful lobbying to increase FDA funding.
Dermapharm shakes up management of Arkopharma subsidiary in Spain with turnaround plan not showing results.
